Assess the Safety and Efficacy of CT0594CP Cells in Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

NCT05893693 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Relapsed and/or Refractory Multiple Myeloma
Plasma Cell Leukemia in Relapse

Interventions

OTHER: Biological

Sponsor

Aibin Liang，MD，Ph.D.

Collaborators

[object Object]